PATENT CLAIM ANALYSIS

Application Number: 15925170
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-10
Patent Classification: ["514", "025000"]

Abstract:
Proton mopping is a new anti-cancer therapeutic approach that disrupts cancer's immunologic balance. It results in the alteration of the pHi/pHe ratio (intracellular-extracellular) of the cancer cell, leading cancer to either normalcy or apoptosis. This technology deploys a chemical compound that has two parts, a glucose part to guide the molecule to the cancer site and a proton neutralizer to mop up the protons. Proof of the validity of this therapeutic approach came after using an existing chemical compound 2-[2(2-Aminoethoxy)ethoxy]ethyl a-D-mannopyranoside, C 12 H 25 NO 8 , which has the above mentioned properties. This compound is of the class of functionalized PEGylated glycosides, which are ligands for conjugation to biological molecules.

Claim (Index 5):
Said chemical compound, according to  claims 1 ,  2  and  3 , further comprising the proton mopping part to be either of the amine NH 2  family or equivalent proton acceptor.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 90.0
- Lexical Diversity: 1.48315
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13147751', '16315264', '15331446', '10447585', '14123448']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7122811709763947
- 35 USC 102 Novelty (BERT): 0.4869632680789228
- Combined Prediction Score: 0.6897493806866475
- Mean Citation Score: 128.90256000000002
- Max Citation Score: 130.65898
- Similarity Product: 80.36757101188064

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test